Comparison
Omega-3 (DHA/EPA) vs Quercetin
Omega-3 (DHA/EPA)
Essential fatty acids critical for brain structure and function. DHA comprises ~40% of brain polyunsaturated fatty acids.
Quercetin
Flavonoid found in onions, apples, capers. Senolytic (especially with dasatinib), antiviral, anti-inflammatory.
| Field | Omega-3 (DHA/EPA) | Quercetin |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 1000–3000mg | 250–1000mg |
| Half-life | 24h | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●● | ●●●●○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 5200 | 4600 |
The comparison in plain English
Auto-generated from dataOmega-3 (DHA/EPA) and Quercetin are both in the neuroprotective category respectively. Omega-3 (DHA/EPA) Essential fatty acids critical for brain structure and function. Quercetin Flavonoid found in onions, apples, capers.
Bottom line
Omega-3 (DHA/EPA) (evidence A, safety 5/5) has a weaker evidence base than Quercetin (evidence B, safety 4/5). Omega-3 (DHA/EPA) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Omega-3 (DHA/EPA) if
Omega-3 (DHA/EPA) is the better fit when your goal aligns with its mechanism (DHA (docosahexaenoic acid) is a structural component of neuronal cell membranes, maintaining fluidity and supporting receptor function) and the dose range (1000–3000mg) suits your protocol. Half-life is 24h.
Choose Quercetin if
Quercetin is the better fit when your goal aligns with its mechanism (Senolytic activity that is substantially amplified when combined with the prescription drug dasatinib — this combination (D+Q) is the most-studied senolytic intervention in current human trials) and the dose range (250–1000mg) suits your protocol. Half-life is —h.